During osteoarthritis progression, production of ECM components is substantially altered, including collagen I, collagen II, aggrecan, and Runx‐2, which changes the microenvironment of the cartilage and disrupts its integrity.22 The gene discussed is RUNX2; the disease is osteoarthritis.